MAZZA, MARIO GENNARO
 Distribuzione geografica
Continente #
NA - Nord America 340
EU - Europa 287
AS - Asia 154
SA - Sud America 2
OC - Oceania 1
Totale 784
Nazione #
US - Stati Uniti d'America 330
SE - Svezia 109
CN - Cina 85
IT - Italia 81
SG - Singapore 47
RU - Federazione Russa 31
DE - Germania 21
FI - Finlandia 16
CA - Canada 9
HK - Hong Kong 8
ES - Italia 6
IE - Irlanda 5
IN - India 4
NL - Olanda 4
UA - Ucraina 4
GB - Regno Unito 3
IR - Iran 3
TR - Turchia 3
BE - Belgio 2
BR - Brasile 2
GR - Grecia 2
ID - Indonesia 2
RS - Serbia 2
AT - Austria 1
AU - Australia 1
CR - Costa Rica 1
JP - Giappone 1
LK - Sri Lanka 1
Totale 784
Città #
Ashburn 74
New York 42
Singapore 36
Shanghai 33
Boardman 21
Lawrence 21
Milan 21
Princeton 21
Washington 20
Rome 17
Helsinki 15
Moscow 12
Dallas 10
Kunming 6
Dublin 5
Hong Kong 5
Barcelona 4
Los Angeles 4
Pune 4
Athens 3
Brookings 3
Chions 3
Los Alamos 3
Oakville 3
San Mateo 3
Toronto 3
Bandung 2
Bologna 2
Brussels 2
Buccinasco 2
Donostia / San Sebastian 2
Düsseldorf 2
Goiânia 2
Hangzhou 2
Inzago 2
Istanbul 2
Laurel 2
Novi Sad 2
Seattle 2
Taizhou 2
Veroli 2
Andover 1
Arenzano 1
Ariccia 1
Boston 1
Cassolnovo 1
Chaozhou 1
Colombo 1
Coventry 1
Ely 1
Falkenstein 1
Foce 1
Fuzhou 1
Granby 1
Guangzhou 1
Harbin 1
Jiaxing 1
Kish 1
Krimpen Aan Den Ijssel 1
Lainate 1
Lappeenranta 1
Linz 1
London 1
Monfalcone 1
Nanjing 1
Nuremberg 1
Prien am Chiemsee 1
Reston 1
San José 1
Santa Clara 1
Tianjin 1
Weitang 1
Xuzhou 1
Totale 454
Nome #
Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: A proof-of-concept study 52
Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: A systematic review and meta-analysis 49
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 37
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 36
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 36
Antidepressant psychopharmacology: is inflammation a future target? 36
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 33
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 28
One-year mental health outcomes in a cohort of COVID-19 survivors 26
Circulating inflammatory markers impact cognitive functions in bipolar depression 24
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence" 24
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 23
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 23
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? 22
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment 21
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 20
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 20
Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue 19
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 19
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 18
The Burden of Survivorship: Survivor Guilt and Its Association with Psychiatric Sequelae in COVID-19 Patients 17
Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study 17
Higher Interleukin 13 differentiates patients with a positive history of suicide attempts in major depressive disorder 17
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression 17
Prevalence of depression in SARS-CoV-2 infected patients: An umbrella review of meta-analyses 16
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis 16
Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches 16
Clinical and psychopathological predictors of fatigue in COVID-19 survivors: a machine learning study 15
Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients 15
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health 15
Persistent psychopathology in covid-19 survivors at one-year follow-up 14
Mood-congruent cognitive distortion and processing bias in depressed covid-19 survivors: a comparison with major depressive disorder 14
Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety 13
Rapid antidepressant response to first-line selective serotonin reuptake inhibitors in post-COVID-19 depression 12
Proinflammatory Cytokines Predict Brain Metabolite Concentrations in the Anterior Cingulate Cortex of Patients With Bipolar Disorder 12
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors 10
IN BETWEEN THE PSYCHOLOGICAL AND PHYSIOLOGICAL SELF – THE IMPACT OF COVID-19 PANDEMIC ON THE NEURO-SOCIO-ECOLOGICAL AND INFLAMMATORY MIND-BODY-BRAIN SYSTEM 8
Neural underpinnings of depressive and post-traumatic symptomatology in covid-19 survivors: a voxel-based morphometry study 8
Preferential and sustained platelet activation in COVID-19 survivors with mental disorders 7
Inflammatory mediators in major depression and bipolar disorder 7
Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: a systematic review and meta-analysis 6
Higher Seasonal Variation of Systemic Inflammation in Bipolar Disorder 5
Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients 4
LONG COVID-19 AFTER HOSPITAL DISCHARGE IN FRAIL AND ROBUST PATIENTS 3
Totale 850
Categoria #
all - tutte 9.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 1 0 1 2 0 0 0 0 0
2021/202262 8 0 0 5 16 1 2 5 5 1 15 4
2022/2023210 47 40 17 5 11 24 11 19 21 2 4 9
2023/2024377 12 19 70 36 43 93 8 29 9 9 8 41
2024/2025197 67 26 35 32 37 0 0 0 0 0 0 0
Totale 850